Non-coding RNAs predict recurrence-free survival of patients with hypoxic tumours.

Non-coding RNAs predict recurrence-free survival of patients with hypoxic tumours.
复制标题

DOI:
10.1038/s41598-017-18462-z
复制
发表时间:
2018-01-09
期刊:
影响因子:
4.6
通讯作者:
Bennewith KL
Bennewith KL
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Martinez VD;Firmino NS;Marshall EA;Ng KW;Wadsworth BJ;Anderson C;Lam WL;Bennewith KL

文献摘要

参考文献

被引文献

相似文献

低氧会增加肿瘤的侵袭性,降低患者的存活率。低氧肿瘤患者的不良预后表明,额外的因素调节了肿瘤对低氧的反应。Piwi相互作用RNA(PiRNAs)是一种小的非编码RNA,在基因组稳定性和基因表达的表观遗传调控中起着关键作用。我们报告了癌症类型特异性的piRNA签名在不同的患者中有所不同。然而,在肾癌患者中检测到显著同源的piRNA图谱,这种癌症的特征是由于常见的von Hippel-Lindau因子(VHL)突变或丢失而导致缺氧相关信号的结构性上调。通过研究来自七个器官的缺氧性和非缺氧性肿瘤的>3000 piRNA转录本,我们发现了40个受缺氧调节的piRNA,并在低氧培养的细胞中验证了这一点。此外,在体外,这些受低氧调控的piRNAs的一部分受到VHL/HIF信号的调控。低氧调节的piRNA评分(PISCO)与低氧肿瘤,特别是I期肺腺癌的RFS差相关,这表明即使在早期肿瘤中,低氧调节的piRNA表达也可以预测肿瘤的复发,因此可能具有临床实用价值。
Hypoxia promotes tumour aggressiveness and reduces patient survival. A spectrum of poor outcome among patients with hypoxic tumours suggests that additional factors modulate how tumours respond to hypoxia. PIWI-interacting RNAs (piRNAs) are small non-coding RNAs with a pivotal role in genomic stability and epigenetic regulation of gene expression. We reported that cancer type-specific piRNA signatures vary among patients. However, remarkably homogenous piRNA profiles are detected across patients with renal cell carcinoma, a cancer characterized by constitutive upregulation of hypoxia-related signaling induced by common mutation or loss of von Hippel-Lindau factor (VHL). By investigating >3000 piRNA transcriptomes in hypoxic and non-hypoxic tumors from seven organs, we discovered 40 hypoxia-regulated piRNAs and validated this in cells cultured under hypoxia. Moreover, a subset of these hypoxia-regulated piRNAs are regulated by VHL/HIF signaling in vitro. A hypoxia-regulated piRNA-based score (PiSco) was associated with poor RFS for hypoxic tumours, particularly Stage I lung adenocarcinomas, suggesting that hypoxia-regulated piRNA expression can predict tumour recurrence even in early-stage tumours and thus may be of clinical utility.
DOI: 10.1002/embr.201337642
发表时间: 2014-01
期刊: EMBO REPORTS
影响因子: 7.7
作者:
Choudhry, Hani;Schoedel, Johannes;Oikonomopoulos, Spyros;Camps, Carme;Grampp, Steffen;Harris, Adrian L.;Ratcliffe, Peter J.;Ragoussis, Jiannis;Mole, David R.
通讯作者: Mole, David R.
DOI: 10.1371/journal.pone.0124860
发表时间: 2015
期刊: PloS one
影响因子: 3.7
作者:
Gebert D;Ketting RF;Zischler H;Rosenkranz D
通讯作者: Rosenkranz D
DOI: 10.1074/jbc.m112.373365
发表时间: 2012-08-17
影响因子: 4.8
作者:
Ho, J. J. David;Metcalf, Julie L.;Marsden, Philip A.
通讯作者: Marsden, Philip A.
DOI: 10.1200/jco.2002.20.3.680
发表时间: 2002-02-01
影响因子: 45.3
作者:
Fyles, A;Milosevic, M;Hill, RP
通讯作者: Hill, RP
DOI: 10.1016/j.celrep.2015.07.030
发表时间: 2015-08-18
期刊: Cell reports
影响因子: 8.8
作者:
Barckmann B;Pierson S;Dufourt J;Papin C;Armenise C;Port F;Grentzinger T;Chambeyron S;Baronian G;Desvignes JP;Curk T;Simonelig M
通讯作者: Simonelig M